Dr. Öğr. Üyesi Süreyya Yiğit Kaya

Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15020453 PMID 41598391 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Venetoclax-based treatment in adult relapsed/refractory acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center real-world experience

Journal of Health Sciences and Medicine, 2026

DOI 10.32322/jhsm.1825832 Texte intégral en libre accèsSource : OpenAlex

Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report

Turkish Journal of Hematology, 2026

DOI 10.4274/tjh.galenos.2026.13284 PMID 41914439 Texte intégral en libre accèsSource : OpenAlex

Real-World Experience with Belinostat in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma

Annals of Medical Research, 2026

DOI 10.5455/annalsmedres.2025.07.193 Texte intégral en libre accèsSource : OpenAlex

Direct Second Autologous Stem Cell Transplantation Versus Re-Induction Followed by Transplantation in Relapsed Multiple Myeloma: A Multicenter Real-World Study

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15135045 PMID 42452507 Texte intégral en libre accèsSource : OpenAlex

A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15145401 PMID 42513315 Texte intégral en libre accèsSource : OpenAlex

Enterovirus Encephalitis Developing After Treatment for Follicular Lymphoma: A Case Report

SN Comprehensive Clinical Medicine, 2026

DOI 10.1007/s42399-026-02560-z Source : OpenAlex

Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study

Journal of Thrombosis and Thrombolysis, 2026

DOI 10.1007/s11239-026-03363-8 PMID 42565930 Texte intégral en libre accèsSource : OpenAlex

Real-World Effectiveness and Renal Safety of Foscarnet for CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15166365 PMID 42652768 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15166350 PMID 42652754 Texte intégral en libre accèsSource : OpenAlex

A complete response with daratumumab, venetoclax, azacitidine and dexamethasone in a heavily pre-treated, chemo-refractory early T-precursor acute lymphoblastic leukemia/lymphoma patient

Annals of Hematology, 2025

DOI 10.1007/s00277-024-06118-8 PMID 39847114 1 citation (Europe PMC) Source : OpenAlex

Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm14207294 PMID 41156164 Texte intégral en libre accèsSource : OpenAlex

Long-Term Response to Single-Agent Lenalidomide in an Elderly Patient with Relapsed Hepatosplenic T-Cell Lymphoma

Turkish Journal of Hematology, 2025

DOI 10.4274/tjh.galenos.2025.2025.0252 PMID 40859640 Texte intégral en libre accèsSource : OpenAlex

When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma

Annals of Hematology, 2025

DOI 10.1007/s00277-025-06285-2 PMID 40016397 Texte intégral en libre accèsSource : OpenAlex

Myth or reality: Graft versus host disease after autologous hematopoietic cell transplantation, a multicentre experience

Transplant Immunology, 2025

DOI 10.1016/j.trim.2025.102286 PMID 40907722 Source : OpenAlex

Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm14196813 PMID 41095893 Texte intégral en libre accèsSource : OpenAlex

Successful treatment of steroid-refractory gastrointestinal GVHD with ruxolitinib in a patient after autologous stem cell transplantation: a case report

International Journal of Hematology, 2025

DOI 10.1007/s12185-025-04073-2 PMID 41004031 Source : OpenAlex

Cutaneous cytomegalovirus infection: a case report

Skin Health and Disease, 2025

DOI 10.1093/skinhd/vzaf057 PMID 42222707 Texte intégral en libre accèsSource : OpenAlex

Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm14207367 PMID 41156238 Texte intégral en libre accèsSource : OpenAlex

Treatment Outcomes of Elderly Patients with Mantle Cell Lymphoma: A Multi-center Real-World Data

Indian Journal of Hematology and Blood Transfusion, 2025

DOI 10.1007/s12288-025-01979-z PMID 41522546 Source : OpenAlex

The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History

Clinical Lymphoma Myeloma & Leukemia, 2025

DOI 10.1016/j.clml.2025.10.006 PMID 41206323 Source : OpenAlex

MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, DIAGNOSIS, CLINICAL IMPACT AND MANAGEMENT

Turkiye Klinikleri eBooks, 2025

DOI 10.5336/978-625-395-694-3_p1 Source : OpenAlex

Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience

Leukemia Research, 2024

DOI 10.1016/j.leukres.2024.107484 PMID 38520796 3 citations (Europe PMC) Source : OpenAlex

Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience

Leukemia Research, 2024

DOI 10.1016/j.leukres.2024.107495 PMID 38599153 3 citations (Europe PMC) Source : OpenAlex

Atypical presentation of PJP: hypercalcemia and kidney injury in an allogeneic stem cell transplant recipient

BMC Infectious Diseases, 2024

DOI 10.1186/s12879-024-10074-z PMID 39448907 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients

Indian Journal of Hematology and Blood Transfusion, 2024

DOI 10.1007/s12288-024-01841-8 PMID 39917490 Texte intégral en libre accèsSource : OpenAlex

Urinary Neutrophil Gelatinase-Associated Lipocalin Levels as an Indicator of Early Kidney Injury in Patients with Type 2 Diabetes Mellitus

Lokman Hekim Health Sciences, 2024

DOI 10.14744/lhhs.2023.5001 Source : OpenAlex

Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case

Frontiers in Immunology, 2023

DOI 10.3389/fimmu.2023.1276295 PMID 37901215 18 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient

Annals of Hematology, 2023

DOI 10.1007/s00277-023-05231-4 PMID 37099080 3 citations (Europe PMC) Source : OpenAlex

Acute Myeloid Leukemia in Elderly, Unfit Patients: Analysis of Turkish AML Prospective Registry Database, on Behalf of Acute Leukemia Working Group of Turkish Society of Hematology

Blood, 2023

DOI 10.1182/blood-2023-189714 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Clinical Outcomes and Treatment Patterns of Primary Central Nervous System Lymphoma: Multicenter Retrospective Analysis

Eurasian Journal of Medicine and Oncology, 2023

DOI 10.14744/ejmo.2023.64688 Texte intégral en libre accèsSource : OpenAlex

Recurrent Herpes Infection in Two Cases with Chronic Myeloid Leukemia Using Dasatinib

Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, 2023

DOI 10.47572/muskutd.1015154 Source : OpenAlex

Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder

Leukemia Research Reports, 2023

DOI 10.1016/j.lrr.2023.100369 PMID 37213444 Texte intégral en libre accèsSource : OpenAlex

Primary Thyroid Lymphoma: A Nationwide Retrospective Cohort Analysis of Survival and Determinant Factors

Research Square, 2023

DOI 10.21203/rs.3.rs-3635621/v1 Texte intégral en libre accèsSource : OpenAlex

Prospective Real-World Outcomes of Acute Myeloid Leukemia

Blood, 2023

DOI 10.1182/blood-2023-182800 Texte intégral en libre accèsSource : OpenAlex

Retrospective Analysis of Turkish AML Registry Database, on Behalf of AML Working Group of Turkish Society of Hematology

Blood, 2022

DOI 10.1182/blood-2022-167639 Source : OpenAlex

Brentuximab vedotin related bilateral Purtscher-like retinopathy unresponsive to pulse steroid therapy and intravitreal aflibercept injection

Europe PMC (PubMed Central), 2017

DOI 10.3205/oc000080 PMID 29326861 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Real-World Data in Relapsed Refractory Myeloma Patients Treated with Pomalidomide, a Multicenter Turkish Experience

Kocaeli Üniversitesi - AVESİS, 2017

Source : OpenAlex

Urinary kidney injury molecule-1 levels as a marker of early kidney injury in hypertensive patients.

PubMed, 2016

PMID 25923545 7 citations (Europe PMC) Source : OpenAlex

Akut Myeloid Lösemi Hastalarımızın Retrospektif Değerlendirilmesi

DergiPark (Istanbul University), 1899

Source : OpenAlex

ULUSLARARASI VE ULUSAL YAYINLAR:

Source : page de profil sur medipol.com.tr

 F. Özdemirkıran, Serife Solmaz Medeni, Füsun Özdemirkıran, K. B. Payzın, Kadriye Bahriye Payzın, Ö. G. Sevindik, C. Acar, Ömür Gökmen Sevindik, Celal Acar, D. Türkyılmaz, Doğuş Türkyılmaz, S. Yiğit Kaya, İ. Alacacıoğlu, Süreyya Yiğit Kaya, Ö. Pişkin, İnci Alacacıoğlu, F. Demirkan, Özden Pişkin, H. G. Özsan, Fatih Demirkan, Hayri Güner Özsan, M. A. Özcan, Mehmet Ali Özcan. Paroksismal Nokturnal Hemoglobinürili Olguların Değerlendirilmesi: İki Merkezin Deneyimi. DEU Tıp Derg. 01 Aralık 2014;28(3):139-43. doi:10.18614/deutfd.40684

Source : page de profil sur medipol.com.tr

 Sevindik, Ö. G., Acar, C., Türkyılmaz, D., Kaya, S. Y., Alacacıoğlu, İ., Pişkin, Ö., Özcan, M. A., Demirkan, F., & Özsan, H. G. (2015). Retrospectıve Evaluatıon Of Patıents Treated Wıth Double Fıltratıon Plasmapheresıs. İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi, 19(4), 181-185. https://izlik.org/JA23BZ27JW

Source : page de profil sur medipol.com.tr

 Kaya, Sureyya Yigit, et al. "Belinostat in relapsed/refractory peripheral T-cell lymphoma: A real-world multicenter experience." Annals of Medical Research 33.4 (2026): 178-184. https://www.annalsmedres.org/index.php/aomr/article/view/4910

Source : page de profil sur medipol.com.tr

KİTAPLAR VE KİTAP ÇEVİRİLERİ:

Source : page de profil sur medipol.com.tr

 KAYA, Süreyya YİĞİT, and Güner Hayri ÖZSAN. "AL Amiloidoz." Turkiye Klinikleri Hematology-Special Topics 11.2 (2018): 140-146.

Source : page de profil sur medipol.com.tr

 Kaya, S. Y. (2025). Yaşlı hastada akut lenfoblastik lösemi yönetimi.

Source : page de profil sur medipol.com.tr

N. A. Soyer, S. Savaş, & F. Şahin (Ed.), Yaşlı hastada malign hematolojik hastalıklara yaklaşım (s.23-29). US Akademi.

Source : page de profil sur medipol.com.tr

 Kaya, S. Y. (2023). Vitamin B12 ve folik asit eksikliği anemisi.

Source : page de profil sur medipol.com.tr

D. Çekiç & K. İşsever (Ed.), Genel dahiliyede güncel konular (s. 15-24). Livre de Lyon.

Source : page de profil sur medipol.com.tr